| 國立臺灣大學 |
2010 |
Type I Il-1 Receptor (Il-1ri) as Potential New Therapeutic Target for Bronchial Asthma
|
李志鴻; 王麗潔; 俞欣慧; 林于粲; 楊曜旭; 江伯倫; LEE, JYH-HONG; WANG, LI-CHIEH; YU, HSIN-HUI; LIN, YU-TSAN; YANG, YAO-HSU; CHIANG, BOR-LUEN |
| 臺大學術典藏 |
2010 |
Type I IL-1 receptor (IL-1RI) as potential new therapeutic target for bronchial asthma
|
Chiang B.-L.;Lee J.-H.;Wang L.-C.;Hsin-Hui Yu;Lin Y.-T.;Yang Y.-H.; Chiang B.-L.; Lee J.-H.; Wang L.-C.; HSIN-HUI YU; Lin Y.-T.; Yang Y.-H. |
| 臺大學術典藏 |
2010 |
Type I IL-1 receptor (IL-1RI) as potential new therapeutic target for bronchial asthma
|
Chiang B.-L.;Lee J.-H.;Li-Chieh Wang;Yu H.-H.;Lin Y.-T.;Yang Y.-H.; Chiang B.-L.; Lee J.-H.; LI-CHIEH WANG; Yu H.-H.; Lin Y.-T.; Yang Y.-H. |
| 臺大學術典藏 |
2020-12-18T01:52:51Z |
Type I IL-1 receptor (IL-1RI) as potential new therapeutic target for bronchial asthma
|
Yu H.-H.; Wang L.-C.; Lee J.-H.; Chiang B.-L.; Chiang B.-L.;Lee J.-H.;Wang L.-C.;Yu H.-H.;Yu-Tsan Lin;Yang Y.-H.; YU-TSAN LIN; Yang Y.-H. |
| 臺大學術典藏 |
2021-01-06T08:23:43Z |
Type I IL-1 receptor (IL-1RI) as potential new therapeutic target for bronchial asthma
|
YAO-HSU YANG; Lin Y.-T.; Yu H.-H.; Wang L.-C.; Lee J.-H.; Chiang B.-L.; Chiang B.-L.;Lee J.-H.;Wang L.-C.;Yu H.-H.;Lin Y.-T.;Yao-Hsu Yang |
| 臺大學術典藏 |
2020-12-08T08:20:27Z |
Type I IL-1 receptor (IL-1RI) as potential new therapeutic target for bronchial asthma
|
Chiang B.-L.;Jyh-Hong Lee;Wang L.-C.;Yu H.-H.;Lin Y.-T.;Yang Y.-H.; Chiang B.-L.; JYH-HONG LEE; Wang L.-C.; Yu H.-H.; Lin Y.-T.; Yang Y.-H. |
| 臺大學術典藏 |
2021-07-02T03:41:57Z |
Type I IL-1 receptor (IL-1RI) as potential new therapeutic target for bronchial asthma
|
BOR-LUEN CHIANG; Lee J.-H.; Wang L.-C.; Yu H.-H.; Lin Y.-T.; Yang Y.-H. |
| 國立臺灣大學 |
2016 |
Type I interferon inhibits varicella-zoster virus replication by interfering with the dynamic interaction between mediator and IE62 within replication compartments
|
Ku, Chia-Chi; Chang, Yi-Hsuan; Chien, Yun; Lee, Tsung-Lin; 顧家綺 |
| 臺大學術典藏 |
2022-02-24T08:50:45Z |
Type I interferon inhibits varicella-zoster virus replication by interfering with the dynamic interaction between mediator and IE62 within replication compartments
|
CHIA-CHI KU; Chang, Yi-Hsuan; Chien, Yun; Lee, Tsung-Lin |
| 國家衛生研究院 |
2021-06 |
Type I interferon signaling accelerates liver regeneration by metabolic modulation in noninfectious Conditions
|
Wu, MS;Kuo, YP;Lo, YC;Tsai, DJ;Lai, CY;Chuang, TH;Lin, SY;Tsai, WT;Chung, PJ;Yu, GY |
| 國立成功大學 |
2005-12 |
Type I interferons protect mice against enterovirus 71 infection
|
Liu, Ming-Liang; Yu, Chun-Keung; Wang, Ya-Fang; Lee,Yi-Ping; Chen, Shun-Hua; Yeh, Trai-Ming; Wang, Jen-Reng; Su, Ih-Jen; Wang, Shih-Min; Liu, Ching-Chuan; Lei, Huan-Yao |
| 國立臺灣大學 |
2007 |
Type I Lanyu pig has a distinct maternal genetic lineage remote from Asian and European pigs
|
Wu, C. Y.; Jiang, Y. N.; Chu, H. P.; Li, S. H.; Wang, Y.; Li, Y. H.; Kung, M. S.; Ju, Y. T. |
| 東海大學 |
2010-09 |
Type I phosphatidylinositol phosphate kinase beta regulates focal adhesion disassembly by promoting beta1 integrin endocytosis
|
趙偉廷; Chao, Wei-Ting; Ashcroft, Felicity; Alexes, C.Daquinag; Vadakkan, Tegy; Wei, Zhubo; Zhang, Pumin; Mary, E.Dickinson; Kunz, Jeannette |
| 東海大學 |
2010-06 |
Type I PIP kinase beta regulates focal adhesion disassembly by promoting beta1 integrin endocytosis.
|
Chao, W. T. , Ashcroft, F., Daquinag, A. C., Vadakkan, T., Wei, Z., Zhang, P., Dickinson, M. E. and Kunz, J.; 趙偉廷 |
| 東海大學 |
2010-07 |
Type I PIPK-alpha regulates directed cell migration by modulating Rac1 plasma membrane targeting and activation
|
趙偉廷; Chao, Wei-Ting; Alexes, C.Daquinag; Ashcroft, Felicity; Kunz, Jeannette |
| 東海大學 |
2010-08 |
Type I PIPK-alpha regulates directed cell migration by modulating Rac1 plasma membrane targeting and activation.
|
Chao, W. T., Daquinag, A. C., Ashcroft, F. and Kunz, J.; 趙偉廷 |
| 國立交通大學 |
2019-04-02T05:59:36Z |
Type I superconductivity in Dirac materials
|
Shapiro, B. Ya; Shapiro, I.; Li, Dingping; Rosenstein, Baruch |
| 中國醫藥大學 |
2002-08 |
Type identification of autosomal dominant polycystic kidney disease by analysis of fluorescent short tandem repeat markers
|
林瑋德(Wei-De Lin); 鄔哲源(Wu,Jer-Yuarn); 蔡輔仁(Tsai,Fuu-Jen)*; 高銘聰(Min-Tsung Kao); 李正淳(Lee,Chun-Cheng) |
| 中國醫藥大學 |
2002 |
Type identification of autosomal dominant polycystic kidney disease by analysis of fluorescent short tandem repeat markers
|
Lin, WD; Wu, JY; Tsai, FJ; Gau, MT; Lee, CC |
| 中國醫藥大學 |
2002 |
Type identification of autosomal dominant polycystic kidney disease by analysis of fluorescent short tandem repeat markers
|
Lin, WD; Wu, JY; Tsai, FJ; Gau, MT; Lee, CC |
| 國家衛生研究院 |
2021-07-22 |
Type II alveolar epithelial cell-specific loss of RhoA exacerbates allergic airway inflammation through SLC26A4
|
Do, DC;Zhang, Y;Tu, W;Hu, X;Xiao, X;Chen, J;Hao, H;Liu, Z;Li, J;Huang, SK;Wan, M;Gao, P |
| 國家衛生研究院 |
2005-06-02 |
Type II collagen gene variants and inherited osteonecrosis of the femoral head
|
Liu, YF; Chen, WM; Lin, YF; Yang, RC; Lin, MW; Li, LH; Chang, YH; Jou, YS; Lin, PY; Su, JS; Huang, SF; Hsiao, KJ; Fann, CSJ; Hwang, HW; Chen, YT; Tsai, SF |
| 元智大學 |
2009 |
Type II collagen-chondroitin sulfate- hyaluronan scaffold cross-linked by genipin for cartilage tissue engineering
|
朱一民; Ko, C.S.; Huang, J.P.; Huang, C.W. |
| 亞洲大學 |
2010 |
Type II diabetes as an example - using long-acting insulin combined with oral hypoglycemic agents the effectiveness of converting mixed insulin
|
CHEN CHENG HUNG |
| 臺大學術典藏 |
2020-11-19T03:19:20Z |
Type II diabetes mellitus is associated with a reduced risk of cholangiocarcinoma in patients with biliary tract diseases
|
Tsai M.-S.; PO-HUANG LEE; Lin C.-L.; Peng C.-L.; Kao C.-H. |
